| scholarly article | Q13442814 |
| P2093 | author name string | Asosingh K | |
| Van Camp B | |||
| Van Riet I | |||
| Vande Broek I | |||
| Vanderkerken K | |||
| Leleu X | |||
| Facon T | |||
| Allegaert V | |||
| P2860 | cites work | Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product | Q24310794 |
| Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor | Q24642958 | ||
| Structure and function of hepatocyte growth factor | Q28274665 | ||
| Basement membrane complexes with biological activity | Q28285072 | ||
| Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen | Q28286714 | ||
| Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane | Q28292489 | ||
| Lymphocyte homing and homeostasis | Q29619924 | ||
| Regulation of matrix metalloproteinase expression in tumor invasion. | Q33605726 | ||
| Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer | Q33607176 | ||
| A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival | Q33957196 | ||
| Localization of type IV collagen, laminin, heparan sulfate proteoglycan, and fibronectin to the basal lamina of basement membranes | Q36206940 | ||
| Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse | Q38274283 | ||
| Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3. | Q38308218 | ||
| Proteolytic remodeling of extracellular matrix | Q40952583 | ||
| Emerging multipotent aspects of hepatocyte growth factor | Q41066829 | ||
| Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis | Q41121047 | ||
| Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines | Q41159708 | ||
| Overexpression of the met/HGF receptor in renal cell carcinomas | Q41190769 | ||
| Matrix metalloproteinases and the development of cancer | Q41239245 | ||
| Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth | Q41596252 | ||
| Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells | Q41908223 | ||
| Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases | Q41972231 | ||
| Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells | Q43844074 | ||
| Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma. | Q44259834 | ||
| The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma. | Q47982958 | ||
| Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats | Q60034429 | ||
| Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates | Q70645807 | ||
| Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma | Q73107825 | ||
| Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma | Q73418817 | ||
| Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement | Q74026103 | ||
| Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1 | Q74438273 | ||
| Upregulation of matrix metalloproteinase-9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells | Q74802770 | ||
| A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen | Q78177336 | ||
| P433 | issue | 5 | |
| P921 | main subject | endothelium | Q111140 |
| neoplastic invasiveness | Q112498967 | ||
| P304 | page(s) | 976-982 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Leukemia | Q6534498 |
| P1476 | title | Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor | |
| P478 | volume | 18 |
| Q38736038 | Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in Bone. |
| Q28288148 | Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade |
| Q34155848 | Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis |
| Q39724856 | Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells |
| Q46698294 | Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells |
| Q52535430 | Endothelial progenitor cells in multiple myeloma neovascularization: a brick to the wall |
| Q38932298 | Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche |
| Q36977712 | Extravasation and homing mechanisms in multiple myeloma |
| Q36973696 | Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma |
| Q40258611 | Hepatitis C Virus E1 protein promotes cell migration and invasion by modulating cellular metastasis suppressor Nm23-H1. |
| Q36414523 | Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma |
| Q36794225 | Involvement of the arachidonic acid cytochrome P450 epoxygenase pathway in the proliferation and invasion of human multiple myeloma cells |
| Q24570128 | Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls |
| Q53285654 | Liver‐specific overexpression of matrix metalloproteinase 9 (MMP‐9) in transgenic mice accelerates development of hepatocellular carcinoma |
| Q36453354 | Microarray-based understanding of normal and malignant plasma cells |
| Q35103092 | Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model |
| Q33820258 | Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias. |
| Q38073136 | Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes |
| Q37132903 | Novel anti-myeloma agents and angiogenesis. |
| Q40115129 | Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK. |
| Q38246971 | Regulation of the metastasis suppressor Nm23-H1 by tumor viruses |
| Q40397931 | Targeting an MMP-9-activated prodrug to multiple myeloma-diseased bone marrow: a proof of principle in the 5T33MM mouse model |
| Q28075927 | The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential |
| Q40330087 | The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM model |
| Q132730932 | The myeloma bone marrow environment and survival signaling |
| Q37718435 | Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model |
| Q42255958 | Thyroid hormone regulates adhesion, migration and matrix metalloproteinase 9 activity via αvβ3 integrin in myeloma cells |
| Q40084237 | Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice |
| Q47733010 | VEGF, ANGPT1, ANGPT2, and MMP-9 expression in the autologous hematopoietic stem cell transplantation and its impact on the time to engraftment. |
| Q34306330 | Variation in innate immunity genes and risk of multiple myeloma |
Search more.